.jpg)
.png)
All
The Foundation of the National Lipid Association (FNLA) supports patient and clinician educational, research, and community outreach activities that enhance and support the initiatives of the NLA in its efforts to reduce cardiovascular events and deaths related to abnormalities of cholesterol... more
The National Lipid Association (NLA) was in attendance at the recent American College of Cardiology (ACC) Annual Scientific Session and Expo 2015, March 14-16, in San Diego. The meeting was dedicated to the diagnosis, prevention and treatment of cardiovascular disease, taking an interactive and... more
THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch of AmgenNow, a new direct-to-patient program starting with Repatha® (evolucumab). This follows landmark results demonstrating Repatha significantly reduced the risk... more
* Indicates required question. Please be as exact as possible. All questions must be answered in order to be eligible. more
What motivated you to become a member of the NLA? A: My passion for lipid management had amplified during my ambulatory care pharmacy residency, where I participated in the pharmacy driven clinics, in part, managing patients with dyslipidemia. Upon completing my residency and beginning my career... more
Dr. Kevin Maki was interested in studying heart disease and diabetes from an early age. Seeing his father and father’s siblings suffer from cardiovascular disease influenced him to begin researching the causes of heart disease while he was still in high school. He quickly became convinced that it... more
Introduction The association of statin use, and incident type 2 diabetes (T2D) is well established in adults.1 Similar observations have not been reported in youth. Despite this association, the benefits of statins in preventing atherosclerotic cardiovascular disease (ASCVD) appear to outweigh... more
Program Overview Join the NLA to Test Your Knowledge! Our panel will explore current and emerging pharmacologic management options for special populations with dyslipidemia. Panelists will present a series of questions, you will make your selection on what you think the correct... more
When Dr. Maria Lopes-Virella and I took on joint editorship of the first issue of LipidSpin all those years ago, I remember feeling like we were responsible for a newborn baby named clinical lipidology. At that time, the National Lipid Association (NLA) had grown from a local lipid association, the... more
For Barbara Wiggins, PharmD, a typical work day involves working up patients, managing medication reconciliation, verifying doses, compliance, and completing rounds as a member of an interdisciplinary health care team. Her spare time is divided into providing input on patient management, counseling... more